Latest Content

Harini Bupathi, Esq, discusses the basis of PBM audits, why they exist, and how pharmacies can anticipate them.

FDA clears first OTC CGM for children 2 years and older, expanding tracking beyond prescriptions for pediatric populations.

How pharmacists differentiate respiratory diseases at the counter.

Pharmacists close these gaps through screening and prevention for patients.

Independent pharmacies combat daily drug shortages with smarter inventory monitoring and diversified suppliers.

This schedule arrives at a time of unprecedented friction between leading medical societies and federal health agencies.

With social determinants of health impacting patient outcomes, researchers assess the viability of community pharmacy partnerships for addressing atrial fibrillation.

In a recent PSG-sponsored webinar, experts present on the growing push toward new-wave pharmacy benefit managers models in pharmacy benefits design.

Pharmacists help patients navigate options by assessing symptoms and selecting appropriate therapy.

Hydrogel-based platforms offer integrated strategies that simultaneously address infection, biofilm persistence, and impaired tissue regeneration.

Despite the boom in prescription weight loss medications, the management of OTC alternatives is still paramount in improving patient outcomes and reducing adverse events.

Pharmacists lead respiratory triage amid overlapping allergy, cold, flu, and COVID-19 symptoms and tackle drug shortages and cardiometabolic care gaps.

In part 2 of our interview with Julia Vu, PharmD, she delves into the AI space within pharmacy practice while touching on the industry’s role in boosting rural health outcomes.

Negative pressure wound therapy has been a staple in hospital settings, but clinical data suggests its benefits are more significant than previously thought.

Lebrikizumab enables 8‑week maintenance dosing for severe eczema, reducing injections to 6 yearly while maintaining strong skin‑clearance results.

AI reshapes everyday tasks in the community pharmacy from refill automation to documentation.

Reports state that everyone from “shadowy online vendors” to physicians and nurses is illegally promoting the drug before it receives proper FDA approval.

Phase 3 data show a once-weekly HIV pill maintains viral suppression like daily therapy, hinting at simpler long-acting care.

This episode explores the true price of commitment to a dream or vision, explaining how anything less than full dedication can lead to failure and why small wins are essential for perseverance.

The decision represents the first new sunscreen ingredient permitted in the United States since the late 1990s.

Alongside malnutrition instances and measles cases, researchers review pneumonia disease burden and immune vulnerability across high-risk pediatric groups.

Based on data from the ADA’s 2026 Scientific Sessions, glucagon-like peptide-1s are continuing to revolutionize the cardiometabolic disease landscape.

Once-weekly mazdutide drives approximately 17% weight loss in Chinese adults with obesity, offering a dual GLP-1/glucagon metabolic option.

Julia Vu, PharmD, joins to discuss industry-impacting NCPDP standards and how they are introducing new processes for medication delivery.

Medicare’s $35 insulin cap cuts cost swings, boosts adherence for high-burden patients, and highlights pharmacists’ role in preventing rationing.

As pneumococcal disease continues to rise since the COVID-19 pandemic, researchers looked at the need to escalate the management of serotype surveillance and vaccine coverage.

BA.3.2 variant spreads globally, testing vaccine matches as the FDA backs XFG immunizations.

The Age-Friendly Pharmacy certification and the 4Ms reshape senior care, teamwork, and deprescribing by putting the patient in the center of care.

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.

Alabama bans research-grade peptides for patients amid FDA reviewing 12 peptides for compounding use.

New 9-year data shows some high-risk prediabetes patients progress to type 2 diabetes despite 8% weight loss.